drugset / Trial / NCT03365908

Pain Management of ACL Reconstruction

NCT03365908 ↗

Enrolling by invitation 60 enrolled University of California, Davis
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare the outcome of pain interventions that are considered standard of care during the surgical treatment of ACL injuries. The comparison will be looking at pain control during and after ACL surgery as well as functional outcomes in patients that had a nerve block versus those who did not. The investigators hypothesize that pain control will be equal between both groups.

Timeline

Start
2017-10-09
Primary completion
2026-07-01
Completion
2026-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 0.5 % —
Subject Ropivacaine Other / unclassified 15 ml —

Indications

No indication recorded.